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ABSTRACT 
Carbon nanotubes exhibit many unique intrinsic physical and chemical properties and 
have been intensively explored for biological and biomedical applications in the past few 
years. In this comprehensive review, we summarize the main results of our and other 
groups in this field and clarify that surface functionalization is critical to the behaviors of 
carbon nanotubes in biological systems. Ultra-sensitive detection of biological species 
with carbon nanotubes can be realized after surface passivation to inhibit the non-specific 
binding of bio-molecules on the hydrophobic nanotube surface. Electrical nanosensors 
based on nanotubes provide a label-free approach to biological detections. Surface 
enhanced Raman spectroscopy of carbon nanotubes opens up a method of protein 
microarray with down to 1 fM detection sensitivity.  In vitro and in vivo toxicity studies 
reveal that well water soluble and serum stable nanotubes are biocompatible, non-toxic 
and potentially useful for biomedical applications. In vivo biodistributions vary with the 
functionalization and possibly also sizes of nanotubes, with a tendency of accumulation 
in the reticuloendothelial systems (RES), including the liver and spleen, after intravenous 
administration. If well functionalized, nanotubes may be excreted mainly through the 
biliary pathway in feces.  Carbon nanotube-based drug delivery has shown promises in 
 2
various in vitro and in vivo experiments including delivery pf small interfering RNA 
(siRNA), paclitaxel and doxorubicin. Moreover, single-walled carbon nanotubes with 
various interesting intrinsic optical properties have been used as novel photoluminance, 
Raman and photoacoustic contrast agents for imaging of cells and animals. Further 
multidisciplinary explorations in this field are promising and may bring new 
opportunities to the realm of biomedicine. 
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1. Introduction 
Nanomaterials have sizes ranging from about one nanometer up to several hundred 
nanometers, comparable to many biological macromolecules such as enzymes, antibodies, 
DNA plasmids, etc. Materials in this size range exhibit interesting physical properties, 
distinct from both the molecular and bulk scales, presenting new opportunities for 
biomedical research and applications in various areas including biology and medicine. As 
an emerging field, nanobiotechnology bridges the physical sciences with biological 
sciences via chemical methods in developing novel tools and platforms for understanding 
biological systems and disease diagnosis and treatment [1-3]. 
Carbon nanotubes (CNTs) are rolled up seamless cylinders of graphene sheets, 
exhibiting many unique physical, mechanical and chemical properties which have 
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gleaned tremendous interest in the past decade [4-8]. Depending on the number of 
graphene layers from which a single nanotube is composed, CNTs are classified as 
single-walled carbon nanotubes (SWNTs) and multi-walled carbon nanotubes (MWNTs). 
Applications of CNTs span many fields and applications, including composite materials 
[9], nano-electronics [10, 11], field-effect emitters [12], and hydrogen storage [13]. In 
recent years, efforts have also been devoted to exploring the potential biological 
applications of CNTs as motivated by their interesting size, shape, and structure, as well 
as attractive, unique physical properties [14-17]. 
With diameters of 1~2 nm, and length ranging from as short as 50 nm up to 1 cm, 
SWNTs are one dimensional (1-D) nanomaterials which may behave distinctly from 
spherical nanoparticles in biological environments, offering new opportunities in 
biomedical research. The flexible 1-D nanotube may bend to facilitate multiple binding 
sites of a functionalized nanotube to one cell, leading to a multi-valence effect, and 
improved affinity of nanotubes conjugated with targeting ligands. With all atoms exposed 
on the surface, SWNTs have ultra-high surface area (theoretically 1300m2/g) that permits 
efficient loading of multiple molecules along the length of the nanotube sidewall. 
Moreover, supramolecular binding of aromatic molecules can be easily achieved by π-π 
stacking of those molecules onto the poly-aromatic surface of nanotubes [18].  
SWNTs are quasi 1-D quantum wires with sharp densities of electronic states 
(electronic DOS) at the van Hove singularities (Fig. 1a), which impart unique optical 
properties to SWNTs [19]. SWNTs are highly absorbing materials with strong optical 
absorption in the NIR range due to E11 optical transitions (Fig. 1a&b), and thus can be 
utilized for photothermal therapy [20, 21] and photoacoustic imaging [22]. 
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Semiconducting SWNTs with small band gaps on the order of 1 eV exhibit 
photoluminescence in the near infrared (NIR) range. The emission range of SWNTs is 
800 nm – 2000 nm [17, 23, 24], which covers the biological tissue transparency window, 
and is therefore suitable for biological imaging. SWNTs also have unique resonance-
enhanced Raman signatures for Raman detection / imaging, with large scattering cross-
sections for single tubes [25, 26]. The intrinsic physical properties of SWNTs can be 
utilized for multimodality imaging and therapy.  
Different from SWNTs, MWNTs are formed by multiple layers of graphene and have 
much larger diameters (10-100 nm). Although MWNTs exhibit less rich and attractive 
optical properties than SWNTs, their use in biological systems could be different from 
that of SWNTs due to their larger sizes, which could offer different platforms for 
different purposes, such as delivery of large biomolecules including DNA plasmids into 
cells [27-30].  
Motivated by various properties of CNTs, research towards applying carbon 
nanotubes for biomedical applications has been progressing rapidly. CNT-based sensors 
have been developed to detect biological species including proteins and DNA [14, 31, 32]. 
Relying on their optical properties, SWNTs can be utilized as optical tags or contrast 
agents for various biological imaging techniques [17, 22, 24, 26]. Others, in addition to 
our group, have uncovered that properly functionalized CNTs are able to enter cells 
without toxicity, shuttling various biological molecular cargoes into cells [15, 16, 29, 33-
36]. Our latest study has shown promise of using CNTs for in vivo cancer treatment in a 
mouse model [37]. However, despite those exciting findings, researchers have reported 
the negative sides of CNTs, showing that non-functionalized nanotubes are toxic to cells 
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and animals [38-43]. The biodistribution and long-term fate of CNTs have been explored 
by us and several different groups, obtaining different results from different methods and 
materials [44-50]. These controversial findings require clarification to avoid confusion to 
the public. 
In this review, we first review various routes used to functionalize carbon nanotubes 
including covalent and non-covalent methods. Carbon nanotube-based electronic and 
optical biosensors are then discussed. Surveying our and others’ results, we next 
summarize that while non-functionalized, hydrophobic CNTs have shown toxicity [38-
43], those with carefully designed biocompatible coatings are harmless to cells in vitro 
[17, 18, 20, 51-57] and in vivo at least to mice within tested dose ranges [45, 58].  In 
terms of biodistribution, although direct comparison between different studies may not be 
fair because of the different CNT materials used, tracking SWNTs themselves by their 
intrinsic physical properties (Raman scattering, photoluminescence, 13C isotope mass 
spectrum) shows that, similar to other nanoparticles in vivo, SWNTs after systemic 
administration are dominantly localized in reticuloendothelial systems (RES) including 
the liver and spleen [45, 48, 50]. Moreover, we review the current progress of using 
carbon nanotubes for in vitro drug delivery studies as well as pioneering efforts towards 
in vivo cancer treatment. Lastly, the SWNT based biomedical imaging in vitro and in vivo 
are discussed. 
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2. Functionalization of carbon nanotubes for biological applications 
As grown, raw carbon nanotubes have highly hydrophobic surfaces, and are not 
soluble in aqueous solutions. Surface chemistry or functionalization is required to 
solubilize CNTs, and to render biocompatibility and low toxicity for biomedical 
applications. Surface functionalization of carbon nanotubes may be covalent or non-
covalent. Chemical reactions forming bonds with nanotube sidewalls are carried out in 
the covalent functionalization case, while non-covalent functionalization exploits 
favorable interactions between the hydrophobic domain of an amphiphilic molecule and 
the CNT surface, affording aqueous nanotubes wrapped by surfactant.  
 
2.1 Covalent functionalization of carbon nanotubes 
Various covalent reactions have been developed to functionalize carbon nanotubes. 
Among them oxidization is one of the most common. CNT oxidization is carried out with 
oxidizing agents such as nitric acid [59, 60].  During the process, carboxyl groups are 
formed at the ends of tubes as well as at the defects on the sidewalls. Zeng et al. observed 
sp3 carbons on SWNTs after oxidization and further covalent conjugation with amino 
acid [61]. However, although oxidized CNTs are soluble in water, they will aggregate in 
the presence of salt due to charge screening effects, and thus cannot be directly used for 
biological applications due to the high salt content of most biological solutions. Further 
modification can be achieved by attaching oxidized CNTs with hydrophilic polymers 
such as poly(ethylene glycol) (PEG), yielding CNT-polymer conjugates stable in 
 7
biological environments (Fig. 2a) [18, 58, 62]. We have used covalently PEGylated 
SWNTs synthesized by this strategy for in vitro and in vivo applications [18, 58]. 
Another type of widely used type of covalent reaction to functionalize CNTs is the 
cylcoaddition reaction, which occurs on the aromatic sidewall, instead of nanotube ends 
and defects as in the oxidization case. [2+1] cycloadditions can be conducted by reacting 
CNTs with azides through photochemistry (Fig. 2b) [63, 64] or carbene generating 
compounds via the Bingel reaction (Fig. 2c) [65, 66]. A 1,3-dipolar cycloaddition 
reaction on CNTs developed by Prato et al. is now a commonly used reaction (Fig. 2d) 
[67, 68]. Azomethine-ylide generated by condensation of an α-amino acid and an 
aldehyde is added to the graphitic surface, forming a pyrrolidine ring coupled to the CNT 
sidewall. Functional groups (e.g. amino-terminated PEG) introduced from the modified 
α-amino acid can be used for further conjugation of biological molecules such as peptides 
or drugs [36, 69].  
Despite the robustness of the covalent functionalization method, the intrinsic physical 
properties of CNTs such as photoluminescence and Raman scattering are often destroyed 
after chemical reactions due to the disrupted nanotube structure. The intensities of Raman 
scattering and photoluminescence of SWNTs are drastically decreased after covalent 
modification, reducing the potential of optical applications of this material.  
 
2.2 Non-covalent functionalization of carbon nanotubes 
In contrast to covalent functionalization, non-covalent functionalization of CNTs can 
be carried out by coating CNTs with amphiphilic surfactant molecules or polymers. Since 
the chemical structure of the π-network of carbon nanotubes is not disrupted, except for 
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shortening of length due to sonication employed in the functionalization process, the 
physical properties of CNTs are essentially preserved by non-covalent approach. 
Consequently, aqueous solutions of CNTs, especially SWNTs, engineered by non-
covalent functionalization are promising for multiple biomedical applications including 
imaging. 
The poly-aromatic graphitic surface of a carbon nanotube is accessible to the binding 
of aromatic molecules via π-π stacking [70, 71]. Taking advantage of the π-π interaction 
between pyrene and the nanotube surface, we and others have used pyrene derivatives to 
non-covalently functionalize carbon nanotubes (Fig. 3a) [70, 72]. Chen et al. showed that 
proteins can be immobilized on SWNTs functionalized by an amine reactive pyrene 
derivative [70].  A recent study conducted by Wu et al. also used pyrene conjugated 
glycodendrimers to solublize carbon nanotubes [72]. Beside pyrene derivatives, single 
stranded DNA molecules have been widely used to solubilize SWNTs by the π-π stacking 
between aromatic DNA base units and the nanotube surface (Fig. 3b) [20, 73, 74]. 
However, a recent report by Moon et al. showed that DNA molecules coated on SWNTs 
could be cleaved by nucleases in the serum, suggesting that DNA functionalization of 
SWNTs might not be stable in biological environments with nucleases [75].  We also 
have shown that fluorescein (FITC) terminated PEG chains are able to solubilize SWNTs 
with the aromatic FITC domain π-π stacked on the nanotube surface, yielding visibly 
fluorescent SWNTs useful for biological detection and imaging [76]. Furthermore, other 
aromatic molecules such as porphyrin derivatives have also been used for non-covalent 
functionalization of CNTs [77]. 
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Various amphiphiles have been used to suspend carbon nanotubes in aqueous 
solutions, with hydrophobic domains attached to the nanotube surface via van der Waals 
forces and hydrophobic effects, and polar heads for water solubility [78]. We used tween-
20 and pluronic triblock copolymer to non-covalently functionalize nanotube surfaces to 
reduce the non-specific binding of proteins in the case of SWNT-based biosensors [14]. 
Pluronic tri-block polymer was used by Cherukuri et al. to solubilize SWNTs for in vivo 
experiments [50]. However, the pluronic coating is not sufficiently stable and is quickly 
replaced by serum proteins once SWNTs are intravenously injected. Other traditional 
surfactants including sodium dodecyl sulfate (SDS) and Triton X-100 have also been 
used to suspend CNTs in water [79].  Carbon nanotubes solubilized by those amphiphiles 
with relatively high critical micelle concentrations (CMC) are typically not stable without 
an excess of surfactant molecules in the solution. Large amounts of surfactants may lyse 
cell membranes and denature proteins, and are therefore not useful in biological 
environments. 
An ideal non-covalent functionlization coating on CNTs for biological applications 
should have the following characteristics. First, the coating molecules should be 
biocompatible and non-toxic. Second, the coating should be stable enough without 
detachment from nanotube surface in biological solutions especially in serum that have 
high salt and protein contents. The amphiphilic coating molecules should have very low 
CMC values so that the nanotube coating is stable after removal of most excess coating 
molecules from the CNT suspension. Lastly, the coating molecules should have 
functional groups which are available for bioconjugation with antibodies or other 
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molecules to create various functional CNT conjugates for different biological 
applications.  
 Non-covalent functionalization of SWNTs by PEGylated phospholipids (PL-PEG) 
was developed by our group to meet the requirements above, including high water 
solubility of nanotubes and versatile functionalities (Fig. 3c) [18, 20, 35, 37, 44]. 
Phospholipids are the major component of cell membranes, and are safe to use in 
biological systems. The two hydrocarbon chains of the lipid strongly anchor onto the 
nanotube surface with the hydrophilic PEG chain extending to the aqueous phase, 
imparting water solubility and biocompatibility. Unlike nanotubes suspended by typical 
surfactants, PEGylated SWNTs prepared by this method are highly stable in various 
biological solutions including serum, and even under harsh conditions without the 
presence of excess PL-PEG (e.g. stable without coating detachment upon heating in 
phosphate buffered saline at 70oC for weeks). PL-PEGs with different PEG lengths and 
structures (linear vs branched) can be used to obtain various PEGylated SWNTs for 
desired applications. Conjugation of biological molecules can be done by using the 
functional group (e.g. amine) at the PEG terminal. Relying on this functionalization 
strategy, we have succeeded in using SWNTs for a range of biomedical applications 
including biological sensing, imaging and drug delivery in vitro with cells or in vivo with 
animals [18, 20, 24, 35, 37, 44, 45, 51]. 
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3. Selective protein-protein interactions on CNTs and biosensor 
applications   
Functionalization strategies as presented above suggest that both single-walled 
and multi-walled carbon nanotubes may present scaffolds for biomolecule 
immobilization, allowing subsequent applications in biosensing, utilizing the intrinsic 
electronic or optical properties of CNTs for signal transduction.  The remarkable physical 
properties of carbon nanotubes, including high surface area, semiconducting behavior, 
band-gap fluorescence, and strong Raman scattering spectra, lend themselves well to 
measuring or detecting proximal or adsorbed biomolecule interactions along the carbon 
nanotube sidewall, at functionalized cap regions [80], and even within the nanotube shell 
[81].  Proximity of reasonably charged or polarized biomolecules yields gating effects on 
isolated semiconducting carbon nanotubes, or net semiconducting networks of CNTs, 
thus yielding field-effect transistors (FETs) capable of quantifying the degree of specific 
or non-specific binding of biomolecules [14].  Moreover, the photoluminescent and 
Raman scattering properties of single-walled carbon nanotubes may be applied to 
biosensing, by specific conjugation of targeting ligands to SWNT tags, coupled with 
sufficient sidewall passivation in order to prevent non-specific binding (NSB).  Owing to 
their length scale and unique structure, carbon nanotubes are of great interest in 
developing highly sensitive and multiplexed biosensors for applications from the 
laboratory to the clinic. 
 
3.1. Non-specific and specific protein-nanotube interactions 
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 In 1999 Balavoine et al reported the crystallization of streptavidin, a biotin-
binding protein expressed in Streptomyces avidinii, on the hydrophobic surface of 
MWNTs.  While stochastic binding of the ~ 70 kDa protein to the nanotube sidewall was 
the major observation, helical packing of a streptavidin monolayer was observed on 
occasion [82].  A similar observation was found for the HupR protein, derived from 
Rhodobacter capsulatis, suggesting that non-specific interactions between proteins and 
carbon nanotubes are common for such water-soluble biomolecules.  
 Our group was the first to report that the interaction between proteins and the 
CNT sidewall is general, and may be ascribed to hydrophobic interactions between the 
exterior fullerene surface and regions of high hydrophobic residue density within the 
protein tertiary structure.  As such, non-specific adsorption of proteins does not appear to 
be dependent upon protein pI and occurs in a variety of buffers and solvents [14, 70, 83, 
84].  To date, non-specific adsorption of a variety of proteins, ranging in size and pI, has 
been observed on both single and multi-walled carbon nanotubes (Fig. 4).   
 The mechanism by which water-soluble proteins interact with bare carbon 
nanotubes was elucidated, both by the discovery of peptides binding directly to fullerene 
surfaces [85, 86], and by discovering methodologies to prevent protein adsorption.  Our 
group demonstrated that amphiphilic coatings, containing poly(ethylene glycol), such as 
Tween-20 and pluronics, were able to effectively decrease the hydrophobicity of the CNT 
sidewall, thus reducing and often eliminating, the non-specific adsorption of proteins [32, 
83, 87].  This result suggested that non-specific protein-CNT interactions were highly 
dependent upon hydrophobic interactions [88], which were thermodynamically unstable 
in the presence of surfactants.   
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A variety of polymers and amphiphiles have been demonstrated for CNT 
passivation, including non-ionic molecules such as PL-PEGs [32], Triton X-100 [83], 
Tween-20, and pluronics [14], all of which contain PEG components.  Resistance to 
protein adsorption appears to scale with both the mass of the hydrophilic PEG block, as 
well as the number of PEG branches.  Surfactant-coated carbon nanotubes immobilized 
on substrates demonstrate degrees of non-specific protein adsorption, ranging from 
partial inhibition of NSB [14] imparted by Triton X-100 (containing linear PEG Mn ~ 400 
Da) to full inhibition by Tween-20 (containing branched PEG, Mn ~ 900 Da) [14, 83].  
Carbon nanotubes that are individualized and suspended in the aqueous phase present 
significantly higher sterically available surface area (by mass) for non-specific protein 
interactions, and thus require greater amounts of PEGylation for sufficient passivation.  It 
was experimentally observed [32] that PL-PEG amphiphiles with PEG Mn ~ 2000 Da did 
not efficiently prevent non-specific protein adsorption, however longer linear PEG (Mn ~ 
5000 Da) or branched PEG (Mn ~ 8000 Da) prevented most interactions.   
 While carbon nanotube-protein interactions can be observed via electron and 
force microscopies, utilization of such supramolecular systems for biosensing requires 
that protein activity and specificity remain intact.  A comparative study between the 
enzymes soybean peroxidase and α-chymotrypsin non-specifically adsorbed onto SWNTs 
revealed varying degrees of specific activity loss, seemingly proportional with protein 
melting temperature and loading density [89].  Loss of specific enzyme activity was 
correlated with inverse proportional changes of α-helices (increased) and β-sheets 
(decreased) composition upon adsorbing onto hydrophobic SWNTs.   
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 For applications of molecular recognition and readout based upon carbon 
nanotubes, ligand-target affinity must be maintained.  Thus, the non-specific 
immobilization of analyte proteins onto the hydrophobic nanotube sidewall is not 
desirable, owing to loss of function and lack of chemical control.  As described above, 
several methods for specific nanotube functionalization exist, however covalent 
modifications to the nanotube sidewall damage the interesting electronic and optical 
properties expected to be utilized as readout mechanisms in biomolecular detection.   
 In order to impart chemical functionality to SWNTs immobilized on substrates or 
suspended in aqueous media (a requirement for most biosensing applications) without 
hindering electrical or optical readout, non-covalent approaches are critical.  Amphiphiles 
have been employed to impart robust functionality to NTs as noted above, and ideal 
candidates for biosensing applications must simultaneously repel non-specific 
interactions and biofouling by including an inert hydrophilic spacer such as poly(ethylene 
glycol).   
Specific protein-nanotube conjugates, synthesized via supramolecular chemistry, 
have been reported in both surface-immobilized and solution phase methodologies.  A 
proof-of-principle study demonstrated the chemically directed conjugation of streptavidin 
to bare SWNTs on Si/SiO2, while non-specific adsorption was prevented by a 
combination of Triton X100 and PEG [83].  Additionally, the surfactant tween-20, 
adsorbed onto substrate-bound nanotubes, was covalently conjugated via 
carbonyldiimidazole to biotin, Staphylococcal protein A (SpA), and U1A antigen [14, 70], 
which imparted specific binding of streptavidin, immunoglobulin G, and the monoclonal 
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mouse antibody 10E6 respectively, while preventing non-specific adsorption of non-
target proteins.   
 
3.2. Electrical detection of protein-nanotube interactions: applications and 
mechanism 
Following the first demonstration of SWNTs acting as molecular sensors via 
field-effect doping by the gaseous species NH3 and NO2 [90], our lab amongst other set 
out to utilize field-effect transistors based upon carbon nanotubes for label-free, highly 
specific biomolecule detection.  Conjugation of biotin, Staphylococcal protein A (SpA), 
and U1A antigen to SWNTs [14, 70], amongst other ligands with specific binding 
characteristics, has been reported to impart specific binding of streptavidin, 
immunoglobulin G, and the monoclonal mouse antibody 10E6 respectively, allowing in 
situ direct detection of these analytes in the nM range via NT FET devices (Fig. 5).   
Surprisingly, in all cases of CNT FET-based detection, conductance across a 
seminconducting network of NTs was reduced following specific analyte protein binding, 
regardless of analyte pI [14, 87].  Further studies revealed the importance of Schottky 
barrier modulation as a result of biomolecule adsorption/binding at nanotube-metal 
electrode contacts in detecting biomolecules with low net charge [87], thus elucidating 
the unexpected gating behaviors observed in FET biomolecule detection.   
Understanding the Schottky barrier modulation mechanism of carbon nanotube 
FETs in biomolecule detection allowed for further improvements to be made in device 
architecture, thus allowing greater sensitivity and lower limits of detection to be coupled 
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with specific binding, imparted by supramolecular ligand conjugations.  Angular shadow 
mask deposition of Au/Cr metal contacts onto semiconducting SWNT networks increased 
the contact area and reduced the contact thickness, in hopes of increasing the Schottky 
barrier modulation component in FET conductance measurement of biomolecules (Fig. 6).  
As hypothesized, increased Schottky barrier area was correlated with improved sensor 
device characteristics, including a reduction in specific detection limit by four orders of 
magnitude, over a ~1 μM to 1 pM range of analyte protein concentration [91].   
A variety of carbon nanotube FETs and electrochemical devices have been 
demonstrated for selective detection of oxidase and dehydrogenase activity, as well as for 
other enzymes and biomolecules of interest, in label-free fashion [92, 93].  However the 
sensitivity of such devices in performing detection of biomolecules is limited by charge 
screening of both CNT-bound ligands and ions common in physiological buffers.. 
Schottky barrier modulation and chemical gating effects of FETs are distant dependent 
processes, thus reducing the utility of CNT FETs for complex (indirect) bioassays. 
Especially troublesome for FET applications in detection of biomolecules is the 
incompatibility of common aqueous buffers with conductance modulated readout.  The 
high ionic strength of physiological buffers, often required to retain protein structure and 
function, shields FET devices from charge-effects of analyte biomolecules, thus reducing 
the simplicity and utility of this detection strategy.   As a result, detection of analyte 
concentrations in the nM to pM range has yielded poor signal-to-noise ratios with these 
devices.   
 
3.3 Photoluminescent detection of proteins based upon seminconducting SWNTs 
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 Exploiting the interesting optical properties of semiconducting SWNTs, rather 
than monitoring their conductance in transistor devices, opens another route for sensitive 
and selective biomolecule detection using these extraordinary materials.  SWNT band 
gap fluorescence [23] has been explored as a methodology for near infrared-imaging of 
both in vitro and in vivo biological systems [17, 24, 26, 50, 94, 95], and holds promise for 
in vitro biomolecule detection assays in both direct and sandwich-assay formats [96-98].  
SWNT NIR fluorescence does not photobleach under high excitation powers and benefits 
from the negligible auto-fluorescence contributions of other assay components in the NIR 
range.  SWNT fluorescence also demonstrates a large Stokes’ shift compared with 
traditional fluorophores, and allows a range of excitation energies to be used. 
 As described above, aqueous phase processing of SWNTs is made possible by 
PEGylated amphiphiles, which reduce biofouling and provide sites of functionality for 
ligand conjugation to the SWNT tags.  Recently, our group has demonstrated specific and 
sensitive detection of biomolecules in sandwich-assay format, using the band-gap 
photoluminescence of SWNTs as NIR fluorophores, with sensitivity from the micromolar 
to the picomolar range (unpublished result).  SWNT NIR fluorescence may be 
multiplexed via microarray printing technology, and unique SWNT fluorophores may be 
obtained by chirality separation [74].  NIR fluorescence detection via SWNT 
fluorophores may facilitate high throughput bioassays with low background contributions 
and thus improved sensitivity over conventional techniques.  
 In addition to direct measurement of SWNT fluorophore emission in 
immunoassay formats, Strano and coworkers have sought to use band gap modulation 
and charge transfer effects via photoluminescence for transduction and quantification of 
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biomolecules such as DNA and glucose.  Non-covalent functionalization of SWNTs with 
24-mer ssDNA and subsequent hybridization of cDNA in proximity to the SWNT surface 
alters the dielectric constant at the SWNT surface, and produces a 2 meV increase in 
band gap energy [97], observed as a blue shift in emission.  Such methodology yields a 
theoretical detection limit of 6 nM of 24-mer DNA.  Moreover, utilizing a similar non-
covalent modification strategy, the same group demonstrated signal transduction via 
fluorescence-quenching for measuring glucose concentrations at physiologically relevant 
conditions, from the micromolar to millimolar range [98].  Direct detection of protein 
binding events by relief of band-gap fluorescence quenching has also been demonstrated.  
Satishkumar et al demonstrated that small molecule quenchers may be removed from 
SWNT surfaces by avidin and albumin in a specific and non-specific manner respectively, 
with detection limits in the micromolar range. [99] 
 In addition to quenching of the inherent SWNT band-gap fluorescence for sensor 
applications, specific detection of biomolecules by quenching may also be realized by 
applying the carbon nanotube as both a scaffold for recognition ligands and as a quencher 
of small-molecule fluorophores.  An excellent example of such quenching-assays is the 
use of molecular beacons in real-time PCR applications.  In comparison with commonly 
used molecular beacons, SWNTs, non-covalently functionalized by FAM-labeled ssDNA, 
demonstrate superior quenching in the unhybridzed state, and thus improved single-to-
noise ratios when hybridized to a complimentary strand.[100]  Additionally, this new 
class of beacon affords improved thermal stability and is general to a wide variety of 
fluorophores.   
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 While SWNT NIR band-gap photoluminescence is promising for biomolecule 
detection, several problems remain to be solved.  While only semiconducting SWNTs 
demonstrate band gap PL, separation and isolation of these fluorophores from other non-
fluorescing SWNT isomers is challenging.  Moreover, the quantum yield of those 
SWNTs that do fluoresce in the NIR is dependent upon their chemical environment, and 
processing is required to avoid quenching and maximize quantum yield [101]. Signal 
transduction via band gap modulation and quenching suffers from the limits of spectral 
resolution, as well as photoluminescence intensity, which limits the utility of these 
methods to analytes at relatively high concentration.  Applications of SWNTs as 
quenchers is promising for detection of ssDNA hybridization, however additional work is 
necessary to monitor protein interactions by this method.  Future elucidation and 
optimization of SWNT fluorescence in the NIR range, as well as isolation of 
semiconducting SWNTs [74, 102] may improve the photoluminescent detection limit of 
SWNT fluorophores in protein assays by many orders of magnitude. 
 
3.4 Surface-enhanced SWNT-Raman tags for highly sensitive detection of proteins 
 
To avoid the issues plaguing SWNT photoluminescence-based detection of 
proteins in vitro, our lab sought to utilize the intense Raman scattering cross-section of 
SWNTs in immunoassay format.  While methodologically similar to fluorescence-based 
sandwich assays [103-105] the application of SWNT Raman tags in lieu of traditional or 
non-traditional [106] fluorophores holds many potential benefits.  In addition to 
scattering efficiencies that rival the quantum yield of organic fluorophores [26] the 
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Raman scattering spectra of SWNTs are simple, with strong, well-definied Lorenztian 
peaks of interest, demonstrating FWHM of 1-3 nm.  As such, the Raman scattering 
spectra of SWNTs are easily distinguishable from noise, and no “auto-scattering” is 
observed for conventional assay surfaces or reagents [32].  Photobleaching and of SWNT 
Raman tags is not observed even under extraordinarily high laser powers, a reflection of 
the stability of the SWNT sp2 carbon lattice.   
 Surface-enhanced Raman scattering (SERS) [106] is a technique that may be 
applied to vastly increase the intensity of Raman active molecules in proximity to 
appropriately tuned surface plasmons, usually associated with gold, silver, or copper 
nanostructures [107].  Coupling the intense resonance-enhancement of 1D SWNT Raman 
tags with SERS presents the opportunity to extend the limit of detection of traditional 
fluorescence assays from approximately 1 pM [108] to the femtomolar level or below.  
By fabricating a gold-coated assay substrate via electron-beam evaporation and 
roughening the gold surface via annealing at 400 ºC in H2 following analyte and tag 
binding, our group was able to demonstrate quantitative SERS over a large area.  While 
such treatment would destroy most small, organic Raman active molecules, SWNTs are 
robust and are undamaged by the process.  This strategy for SERS yielded nearly a 100-
fold increase in SWNT Raman scattering intensity [32](Fig. 7). 
 As previously discussed, non-covalent surfactant wrapping may be used to both 
functionalize and passivate SWNTs.  Recently our group employed SWNTs, suspended 
by linear PL-PEG-NH2 (Mn ~ 5000 Da) and branched PL-PEG-NH2 (Mn ~ 8000 Da) (Fig. 
7), coupled to goat anti-mouse immunoglobulin G (GaM-IgG) for specific detection in 
immunoassays.  To test the selective binding and non-specific behavior of such 
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conjugates, a variety of analyte proteins were immobilized on SERS active substrates, 
and, following incubation with GaM-IgG-SWNTs, selective detection of mouse IgGs was 
observed (Fig. 8).  Extending this methodology to concentration-dependent sandwich 
immunoassays, we have been able to push limits of detection to 1 fM of model analyte, 
approximately three orders of magnitude better than common fluorescence methods. 
Ultra-sensitive protein detection by SWNT Raman tags has been demonstrated not only 
for model analyte, but for true biomarkers of human autoimmune disease [32] and cancer 
(our unpublished results), with dynamic ranges over 6-8 orders of magnitude (Fig. 8).   
Biomolecule detection by SWNT Raman tags appears to be generalizable to 
systems other than high affinity antigen-antibody interactions, including biotin-
streptavidin binding, Protein A/G-IgG interaction and DNA hybridization [32].  By 
coupling the characteristic intense Raman scattering efficiency of 1-D SWNTs with 
quantitative SERS substrates and non-covalent strategies for both specific antibody 
conjugation and non-specific binding passivation highly sensitive biosensors have been 
developed and demonstrated. Moreover, by taking advantage of highly multiplexable 
microarray technology, and employing isotopically-labeled SWNTs (composed of pure 
12C and 13C respectively) our group has demonstrated multi-color detection of multiple 
analytes simultaneously, utilizing only a single excitation source (Fig. 9). The application 
and utility of such sensitive, multiplexed biosensors remains to be fully explored, though 
with recent advances in biomarker discovery [109] there is much promise for detection 
and monitoring of early stage cancer. 
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4. Toxicity of carbon nanotubes 
Safety is the first requirement of any material used in medicine. A large number of 
studies have been performed in the past several years to explore the potential toxic effects 
of carbon nanotubes. The conclusions of these reports varied drastically, showing a large 
dependence on the type of nanotube materials as well as functionalization approaches. 
Cell culture experiments and in vivo pilot studies conducted by various groups observed 
no obvious toxicity of properly functionalized carbon nanotubes [15, 53, 58, 72]. On the 
other hand, raw carbon nanotubes were shown to be toxic to mice after inhalation into the 
lung [39, 40, 110, 111]. Recent research showed that unfunctionalized, long MWNTs 
may pose a carcinogenic risk in mice [43]. As a result of the wide variety of reports, both 
the public and research communities are currently concerned about using carbon 
nanotubes for biomedical applications. It is thus critical and urgent to clarify the toxicity 
issue of carbon nanotubes. The current status is that toxicity appears to be dependent on 
the material preparation, especially geometry and surface functionalization. Well-
functionalized CNTs with biocompatible surface coatings have been shown to be non-
toxic in vitro to cells and in vivo in mice. 
 
4.1 In vitro toxicity of carbon nanotubes 
Even in cell culture experiments, the issue of toxicity of carbon nanotubes is still 
controversial. While inhibition of HEK 293 cell proliferation after exposure to SWNTs 
was observed by Cui et al. [38], Ding et al. observed that MWNTs induce cell cycle 
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arrest and increase apoptosis/necrosis of human skin fibroblasts [41]. However, neither of 
these studies used functionalized carbon nanotubes in the experiments. Apoptosis of T 
lymphocytes induced by oxidized MWNT was observed by Bottini et al. [42]. However 
simple oxidization is not enough to render carbon nanotubes soluble and stable in saline 
and cell medium, and thus dose not represent a biocompatible functionalization. Sayes et 
al. further reported that the toxicity of CNTs was dependent on the density of 
functionalization on nanotubes, with minimal toxicity for those heavily functionalized 
with the highest density of phenyl-SO3X groups on nanotubes [112]. These results are 
understandable because CNTs without proper functionalization have a highly 
hydrophobic surface, and thus may aggregate in the cell culture and interact with cells by 
binding to various biological species including proteins via hydrophobic interactions, to 
induce certain cell responses such as cell toxicity.  
Other factors may also contribute to the observed toxicity of CNT samples in vitro. 
Excess surfactants in the CNT suspensions are known to be highly toxic to cells [113]. 
The metal catalyst content in CNTs should also be considered when the toxicity of carbon 
nanotubes is investigated [114]. Moreover, proper assays must be employed in toxicity 
tests to avoid interference of carbon nanotubes with the assay reagents [115, 116]. For 
these reasons, in vitro toxicity assays of carbon nanotubes should be carefully designed 
and performed with well prepared and characterized materials, as well as suitable assay 
methods.  
We and many other groups successfully used well functionalized, serum stable carbon 
nanotubes for in vitro cellular uptake experiments without observing apparent toxicity 
[17, 18, 20, 51-57]. Cells exposed to SWNTs, PEGylated by various PL-PEG 
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amphiphiles used in our work, exhibited neither enhanced apoptosis/neurosis, nor 
reduced proliferation of various cell lines in vitro [18, 20, 51]. Carbon nanotubes 
covalently functionalized by 1,3-dipolar cycloaddition developed by Prato et al. also 
appeared to be safe to their tested cell lines, including primary immune cells [52, 53]. 
Carbon nanotubes with biomimic coating engineered by Bertozzi et al. were also non-
toxic to cells [54, 55]. Several other independent groups also reported that CNTs coated 
by DNA, amphiphlic helical peptides and serum proteins were not toxic to cells [26, 56, 
57]. The latest finding by Jin et al. discovered that SWNTs taken up by cells via 
endocytosis exited cells through exocytosis without affecting the viability of cells [95]. It 
appears that raw CNTs and CNTs without serum-stable functionalization show toxicity to 
cells at moderate dosage, while serum-stable, functionalized CNTs show little toxicity 
even at high dosages. 
 
4.2 In vivo toxicity of carbon nanotubes 
To address the possible side effects of CNTs on human health and our environment, 
researchers have investigated the toxicology of CNTs in animal models. 
Unfucntionalized raw CNTs have been intratracheally (IT) instilled into animals, 
showing obvious pulmonary toxicity including unusual inflammation and fibrotic 
reactions due to the aggregation of hydrophobic raw CNTs in the lung airways [39, 40, 
110, 111]. Those results suggest that aerosol exposure of raw CNTs in the workplace 
should be avoided to protect human health. Nevertheless, toxicities observed by 
intratracheal instillation of large amounts of raw CNTs may have little relevance to the 
toxicology profile of functionalized soluble CNTs for biomedical applications, especially 
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when they are administered through other routes such as intraperitoneal (IP) and 
intravenous (IV) injections, by which lung airways are not accessible to CNTs. 
In a recent pilot study, Poland et al. noticed asbestos-like pathogenic behaviors such 
as mesothelioma associated with exposing the mesothelial lining of the body cavity of 
mice to large MWNTs (length 10~50 µm, diameter 80~160 nm) following intraperitoneal  
injection [43]. Despite the importance of this finding in the discovery of potential 
negative effects of CNTs to human health, the MWNT materials used in this study are 
simply sonicated in 0.5% bovine serum albumin (BSA) solutions without careful surface 
functionalization and hence are not directly meaningful for functionalized CNTs with 
biocompatible coatings recommended for biomedical applications. Furthermore, length-
dependent pathogenicity was observed, as no obvious toxic effect was observed for 
shorter and smaller MWNTs (length 1~20 µm, diameter 10~14 nm), indicating that the 
toxicology profiles of CNTs may significantly differ between CNTs of various sizes 
(diameter and length). It is worth note that functionalized SWNTs used in typical 
biomedical research have length 50~300 nm and diameter 1~2 nm, which are entirely 
different from the geometry of MWNTs used by Poland et al.   
The first reported in vivo toxicity study of functionalized SWNTs was conducted by 
the Gambhir group and our group [58]. Both covalently and non-covalently PEGylated 
SWNTs were used in this study. Mice intravenously injected with PEGyalted SWNTs 
(~3 mg/kg) were monitored over four months, with systolic blood pressure, complete 
blood counts and serum chemistry recorded every month.  Careful necropsy and tissue 
histology examinations were performed at the end of 4 months. Normal blood chemistries 
and histological observations were observed in this study, suggesting that functionalized 
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biocompatible SWNTs may be safe for in vivo biological applications. Another separate 
study by our group showed similar results, suggesting that PEGylated SWNTs are slowly 
excreted from the body following systemic distribution in mouse models, without 
exhibiting obvious toxicity in the process [45]. Recently, Yang et al. showed in a 3 month 
toxicity study that SWNTs suspended by Tween-80, which is likely not an ideal coating 
molecule, exhibited low toxicities to the tested mice at a very high dose (~40mg/kg) 
following i.v. administration. Such toxicity may be due to the oxidative stress induced by 
SWNTs accumulated in liver and lung [117]. The toxicity observed was dose dependent, 
and appeared to be less obvious at lower doses (2mg/kg and 16mg/kg). Another recent 
report by the same group showed that their covalently PEGylated SWNTs, with much 
higher aqueous stabilities and biocompatibilities, exhibited an ultra-long blood circulation 
half-life in mice [118]. Although the long-term toxicology of such “improved” SWNTs 
has yet to be determined, no acute toxicity has been reported even at a high dose 
(24mg/kg).  
To fully address the toxicity concern of CNTs, further investigations, including 
animal models other than mice, and at larger scales, are still required. Moreover, the 
interactions between administered CNTs and the immune complement system, whose 
activation is an important first defense line against foreign species, especially microbes, 
requires more attentions [119]. Moreover, increased efforts are needed not only from the 
chemical approach, i.e. further optimizing CNT surface chemistry and geometry for 
improved biocompatibility, but also from those with biological expertise, to 
systematically study the complete CNT toxicology profile in different animal models 
with different routes of administration. 
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5. In vitro delivery of biomolecules by carbon nanotubes 
The work of using carbon nanotubes for drug delivery in our group was triggered by 
an unexpected finding that functionalized CNTs are able to enter cells by themselves 
without obvious toxicity [15]. Similar results were published by the Prato group around 
the same time [36]. The CNT cellular uptake mechanism may differ depending on the 
functionalizations and sizes of the CNTs, including endocytosis as reported by us and 
several other groups [15, 26, 34, 56, 95], or passive diffusion as observed by the Prato 
group when CNTs are functionalized by 1,3-dipolar cycloaddition [16, 120]. CNTs have 
been used to efficiently shuttle various biological cargoes, ranging from small drug 
molecules to bio-macromolecules, such as protein and DNA/RNA, into different types of 
cells. Once taken up by cells via endocytosis, SWNTs are able to exit cells through 
exocytosis [95].  
 
5.1 Delivery of small drug molecules by carbon nanotubes 
Small drug molecules can be covalently conjugated to CNTs for in vitro delivery. 
Fluorescent dyes and drug cargos were simultaneously linked to 1,3-dipolar 
cycloaddition functionalized CNTs via amide bonds for the delivery of an anti-cancer 
drug [69] or an anti-fungi drug [52] into cells. In collaboration with our group, Feazell 
and Lippard used non-covalently PEGylated SWNTs (by PL-PEG, Mn~2000 Da) as a 
longboat delivery system to internalize a platinum(IV) complex, a prodrug of the 
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cytotoxic platinum (II), into cancer cells [121]. The inert platinum(IV) prodrug 
compounds developed by the Lippard group are activated only after being reduced to the 
active platinum(II) form. SWNTs tethered with the platinum(IV) complexes through 
peptide linkages are taken into cancer cells by endocytosis and reside in cell endosomes, 
where reduced pH induces reductive release of the platinum(II) core complex, thus 
killing the cancer cells. The cytotoxicity of the platinum(IV) complex increases over 100-
fold after attachment to SWNTs. We have also conjugated paclitaxel, a commonly used 
anti-cancer drug, to branched PEG-coated SWNTs via a cleavable ester bond  [37]. The 
SWNT-PTX conjugate was tested both in vitro and in vivo. 
Beside covalent conjugation, a novel non-covalent supramolecular chemistry has 
been uncovered in our lab, for loading aromatic drug molecules to functionalized SWNTs 
by π-π stacking (Fig. 10a&b) [18]. Doxorubicin, a commonly used cancer chemotherapy 
drug, can be loaded on the surface of PEGylated SWNTs with remarkably high loading, 
up to 4 gram of drug per 1 gram nanotube, owing to the ultra-high surface area of 
SWNTs. The loading/binding is pH dependent and favorable for drug release in 
endosomes and lysosomes, as well as in tumor micro-environments with acidic pH (Fig. 
10c). Similar drug loading behaviors have been reported for MWNTs [122], single-
walled carbon nanohorns [123] and nano-graphene oxide [124, 125]. The supramolecular 
approach of drug loading on CNTs opens new opportunities for drug delivery. 
Targeting ligands including folic acid [20, 126], peptides [18, 44] and antibodies [24, 
127-129] have been used to target CNTs to specific types of cells in vitro or to tumors in 
vivo. Targeted drug delivery with CNTs requires conjugation of both targeting molecules 
and drug molecules to the same nanotube, and thus requires carefully designed strategies 
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[18, 126]. In the work reported by Dhar et al., folic acid (FA) was linked to a Pt(IV) 
prodrug compound, and then conjugated to PEGylated SWNTs [126], yielding a SWNT-
Pt(IV)-FA conjugate that showed enhanced toxicity to folate receptor (FR) positive cells 
but not to FR negative cells as the result of FA targeted delivery. For the delivery of 
aromatic drugs such as doxorubicin, which are directly loaded on the nanotube surface 
via π-π stacking, the functional groups on the SWNT coating molecules (e.g. PL-PEG-
amine) can be conjugated with targeting molecules such as Arg–Gly–Asp (RGD) peptide 
for targeted delivery (Fig. 10a) [18]. 
Besides drug conjugation and loading outside nanotubes, the hallow structure of 
CNTs may allow the encapsulation of drug molecules inside nanotubes for drug delivery. 
Fullerene balls[130], metal ions[131], small compounds such as metallocenes [132], and 
even DNA molecules[133] have been encapsulated inside CNTs. Although a number of 
theoretical modeling studies predicted the insertion of biomolecules including 
chemotherapy drugs[134, 135] into CNTs, drug delivery by encapsulation of drugs inside 
CNTs has been rarely reported. Further experimental explorations are still needed to 
examine the possibility of the encapsulation strategy in CNT based drug delivery.  
 
5.2 Delivery of biomacromolecules by carbon nanotubes 
Unlike various small drug molecules which are able to diffuse into cells, 
biomacromolecules including proteins, DNA and RNA rarely cross cell membranes by 
themselves. Intracellular delivery is thus required in order to use those molecules for 
therapeutic applications. Proteins can be either conjugated or non-covalently absorbed on 
nanotubes for intracellular delivery [15, 33]. The hydrophobic surface of partially 
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functionalized SWNTs (e.g. oxidized SWNTs) allows non-specific binding of protein. 
After being translocated into cells by nanotubes, proteins can become bioactive once they 
are released from endosomes [33] . 
CNTs can be modified with positive charges to bind DNA plasmids for gene 
transfection [27-30]. Pantarotto et al. and Singh et al. used amine-terminated SWNTs and 
MWNTs functionalized by 1,3-dipolar cycloaddition to bind DNA plasmids, and have 
achieved reasonable transfection efficiency [27, 29]. In the work of Gao et al., amine 
groups were introduced to oxidized MWNTs for DNA binding and transfection, 
successfully expressing green fluorescence protein (GFP)-expressing mammalian cells. 
Although the MWNT based method was less efficient than commercial gene transfection 
agents, such as lipofectamine 2000, the MWNTs exhibited much lower toxicity [30]. In 
another study carried out by Liu et al., polyethylenimine (PEI) grafted MWNTs were 
used for DNA attachment and delivery, which afforded comparable efficacy to the 
standard PEI transfection method with the benefit of reduced cytotoxicity [28].  
 Small interfering RNA (siRNA) is able to silence specific gene expression via RNA 
interference (RNAi) and has generated a great deal of interest in both basic and applied 
biology [136]. Although viral based siRNA delivery method has shown promise in 
animal models as well as clinical trials, the safety concern of viral vectors is signficant. It 
is thus important to develop non-viral vectors for siRNA delivery [137, 138]. With a 
cleavable disulfide bond linkage between siRNA and SWNTs, we successfully delivered 
siRNA into cells by nanotubes and observed gene silencing effect (Fig. 11a) [35]. We 
further showed that our SWNT based siRNA delivery was applicable to those hard-to-
transfect human T cells and primary cells, which were resistant to delivery by 
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conventional cationic liposome-based transfection agents (Fig. 11 b&c).[51] Surface 
functionalization dependent cell uptake of SWNTs was observed. Compared with 
SWNTs coated with long PEG (5.4 kDa), shorter PEG (2 kDa) coated SWNTs with more 
hydrophobic surface exposed showed higher cellular uptake, which was favorable for 
siRNA delivery into cells (Fig. 11d). We proposed that our SWNTs functionalized with 
short PEG (2kDa) retained certain hydrophobicity (due to incomplete coverage of 
nanotube sidewalls), which could cause binding and association with cells, resulting from 
hydrophobic interactions with hydrophobic cell membrane domains.  The cell binding of 
SWNTs is an important first step for cellular entry via endocytosis. Our results suggest 
that balanced chemical functionalization schemes that impart sufficient aqueous 
solubility and biocompatibility to nanotubes, and retain the ability of nanotube binding 
with cell surfaces are important for intracellular delivery of biomacromolecules by CNTs. 
Beside our work, other CNT based siRNA delivery has also been reported, showing 
efficacy in vitro and even in vivo [139]. 
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6. In vivo biodistribution and long term fate of carbon nanotubes 
Encouraged by the successes of using CNTs for in vitro sensing, drug delivery and 
imaging, research in this field has moved to in vivo animal research. The first critical 
question to address is the biodistribution profile of CNTs after systemic administration 
into animals and any toxicity. In the past few years, in vivo biodistribution and 
pharmacokinetics studies were carried out by a number of groups using different CNT 
materials, different surface functionalizations, and different tracking methodologies, thus 
obtaining various and sometimes controversial results.  
Radio-labeled (111In-DTPA) SWNTs and MWNTs functionalized by 1,3-dipolar 
cycloaddition were used by Singh et al.[46] and Lacerda et al.[47] to determine 
biodistribution. Surprisingly, after intravenous injection of CNTs into mice, they 
observed fast urinal clearance of CNTs, with the majority (>95%) cleared out within 3 
hours, and no uptake in RES organs such as the liver and spleen. Those phenomena were 
similar to the in vivo behaviors of small molecules, but drastically differed from that 
expected of most nanoparticles with sizes exceeding the glomerular filtration threshold. 
To explain their results, the researchers proposed that despite finite lengths, the small 
diameters of CNTs allowed for fast urinal excretion of CNTs. However, this conclusion 
is debatable considering well-characterized size dependent protein biodistribution and 
excretion behaviors (Table 1, proteins larger than 7-9nm start showing high RES uptake 
and limited renal excretion) and also contradictory findings in a study reported by Choi et 
al. using quantum dots (QDs) [140]. It is found that the size limitation of spherical QDs 
to undergo fast urinal excretion is ~6 nm, including coating molecules [140], which is 
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indeed larger than the diameter of individual SWNTs (1-2nm). However, the QDs were 
but much smaller than the diameter of SWNT bundles (10-40nm) [46] or MWNTs (20-
30nm) [47] used in these two CNT biodistribution studies. The reported fast CNT urinal 
excretion requires confirmation.  
Several other labs have also studied the biodistribution of radio-labeled CNTs in mice. 
Wang & Liu et al. reported relatively slow urinal excretion and low RES uptake in their 
first study [141]. Later reports by the same group using 14C-taurine functionalized CNTs, 
however, revealed dominant and persistent liver accumulation of CNTs after intravenous 
injection [49, 142]. Another independent study by McDevitt et al. using antibody 
conjugated radio-labeled CNTs functionalized by 1,3-dipolar cycloaddition also showed 
high CNT uptake in the liver and spleen with slow urinal excretion [129]. A significant 
amount of CNTs remained in the body even after 15 days. We have also investigated the 
biodistribution of radio-labeled, PEGylated SWNTs, observing dominant SWNT uptake 
in RES organs, including liver and spleen, without rapid clearance [44]. Although the 
radiolabel method is a convenient way to examine the biodistribution of a substance, 
excess free radio isotopes in the radio-labeled CNT samples, if not completely removed, 
may lead to false results, especially for excretion as free radio isotopes are small 
molecules that are rapidly excreted through urine after intravenous injection. Also, 
radiolabels could gradually release from CNTs in vivo, and be slowly excreted in the free 
form. As a consequence, radio-labeling is not an ideal strategy to study the excretion and 
long term fate of CNTs. 
Without using radiolabels, researchers have investigated the in vivo behaviors of 
SWNTs relying on their intrinsic properties. Individual semi-conducting SWNTs exhibit 
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NIR photoluminescence, which has been used by Cherukuri et al. to track nanotubes in 
rabbits [50]. Without detailed biodistribution data, the authors observed SWNT 
photoluminance signals in the liver but not in other organs such as kidney. In another 
study, Yang et al. used isotope ratio mass spectroscopy to examine the biodistribution of 
13C enriched unfunctionalized SWNTs over a month, showing high nanotube uptake in 
lung, liver and spleen without apparent excretion within 28 days [48]. Taking advantage 
of the bright Raman scattering signatures of SWNTs, we used Raman spectroscopy to 
study the long-term fate of nanotubes in mice [45]. It was uncovered that our PEGylated 
biocompatible SWNTs were dominantly accumulated in liver and spleen after 
intravenous administration, but slowly excreted within months, likely via the biliary 
pathway into the feces. There could be a small portion of SWNTs with very short lengths 
that were extreted through urinal elimination, as indicated by the weak SWNT Raman 
signal observed in the mouse kidney and bladder.  
Most importantly, we have systematically studied the relationship between PEG 
coating and the in vivo behaviors of SWNTs. Prolonged blood circulation time is 
generally desired for drug delivery and tumor targeting. We have concluded that long 
PEG coatings on SWNTs generally confer a prolonged blood circulation half-life, 
reduced RES uptake and accelerated excretion (Fig. 12). Moreover, PEG with branched 
structure offers a more efficient coating on SWNT surface than linear PEGs, and allows a 
longer SWNT blood circulation half-life, which is ~5 h for branched PEG compared with 
~2 h for linear PEG at the same molecular weight (7kDa) (Fig. 12) [45]. Another recent 
study by Yang et al. obtained an even longer blood circulation half-life (22 h) using 
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covalently PEGylated SWNTs [118]. Those results are thus illuminative to the future 
research of carbon nanotubes for in vivo biomedical applications. 
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Biodistribution 
(%ID/g at 4 h) Protein 
Molecule 
 
MW 
(kDa) 
 
d 
(nm) 
liver spleen kidney 
Blood 
half-life 
(min) 
Whole 
body 
half-life 
(h) 
ScFv [143] 30 
5.3 
[140] 
1.3 0.9 0.8 <10 ~3.8 
Fab' [143] 50 
6.0 
[144] 
1.3 1.8 21.5 ~30 ~6.7 
Sc(Fv)2 [143, 
145] 
60 
7.0 
[140] 
2.0 2.8 2.9 78 ~10 
F(ab’)2 [143] 100 - 7.8 7.1 9.8 ~200 ~20 
[sc(Fv)2]2 
[145] 
120 
9.3 
[140] 
7.0 6.2 3.6 170 - 
IgG [143, 
145] 
152 
11 
[144] 
18.7 18.0 4.7 330 ~80 
 
Table 1. Biodistribution and pharmacokinetics of proteins with different sizes. Small 
proteins with diameter below 6~7 nm are quickly excreted through urinal clearance with 
very short blood circulation and whole body retention half-lives. Bigger proteins in 
contrast show high uptake in RES organs and much longer blood and whole body half-
lives. They are unable to undergo fast urinal excretion because of their large sizes.  
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7. In vivo tumor targeting and preliminary effort towards in vivo cancer 
therapy 
In order to use CNTs for potential cancer treatment and/or imaging, targeting 
nanotubes to tumors is highly desired. Both passive targeting, relying on the enhanced 
permeability and retention (EPR) effect of cancerous tumors, and active targeting guided 
by tumor targeting ligands, have been applied for various nanoparticle-based drug 
delivery systems. Thus far there are two published papers reporting in vivo tumor 
targeting by CNTs conjugated with targeting ligands. We showed that efficient tumor 
targeting was achieved by conjugating an Arg–Gly–Asp (RGD) peptide, which 
recognizes integrin αvβ3, up-regulated on various solid tumor cells and tumor 
vasculatures, to PEGylated SWNTs [44]. SWNTs with two different PEG coatings 
conjugated with both RGD peptide and radiolabels (64Cu-DOTA) were intravenously 
injected in to glioblastoma U87MG tumor bearing mice, which were monitored by micro-
positron emission tomography (micro-PET) over time (Fig. 13). RGD conjugated 
SWNTs with long PEG coating (SWNT-PEG5400-RGD) exhibited a high tumor uptake of 
~13 % of injected dose per gram tissue (%ID/g), compared with 4~5 %ID/g obtained 
with plain SWNTs without RGD (SWNT-PEG5400). Interestingly, we uncovered that 
efficient tumor targeting could only be realized when SWNTs were coated with long 
PEG (SWNT-PEG5400-RGD) but not with short PEG (SWNT-PEG2000-RGD). The latter 
had short blood circulation time, and thus lower probability to be trapped in tumors or 
bind the tumor receptors. Our data suggest that surface functionalization of SWNTs is 
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also important for tumor targeting in vivo. Another study carried out by McDevitt et 
al.[129] showed tumor targeting of CNTs by antibody conjugation.  
The first in vivo cancer treatment study with CNTs was reported by Zhang et al. using 
positively charged SWNTs to delivery therapeutic siRNA into cancer cells [139]. 
However, this was a proof-of-concept study, with SWNT-siRNA complexes directly 
injected into tumors, instead of systemic administration. Our recent work showed that 
paclitaxel (PTX), a commonly used chemotherapy drug, may be conjugated to branched 
PEG functionalized SWNTs via a cleavable ester bond (Fig. 14a) [37]. The SWNT-PTX 
conjugate was tested in a 4T1 murine breast cancer model in mice, exhibiting improved 
treatment efficacy over the clinical cremophor-based PTX formulation, Taxol® (Fig. 
14b). Pharmacokinetics and biodistribution studies revealed longer blood circulation half-
life and higher tumor uptake of SWNT-PTX than those of simple PEGylated PTX and 
Taxol®, consistent with the observed efficacies of different PTX formulations. The high 
tumor passive uptake of SWNT-PTX was likely due to the EPR effect. In addition, PTX 
molecules carried to RES organs (e.g. liver and spleen) by SWNTs were rapidly 
dissociated from nanotubes and excreted, diminishing the RES toxicity of this SWNT-
based PTX formulation. Our work is the first one to show that carbon nanotubes can be 
used for in vivo drug deliver for cancer therapy by systemic administration [37]. 
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8. Biological imaging using carbon nanotubes 
In addition to applications for drug delivery and treatment, the intrinsic optical 
properties of SWNTs make them useful as optical probes.  Owing to their quasi 1-D 
nature, SWNTs exhibit strong resonance Raman scattering, high optical absorption and 
photoluminescence in the near-infrared (NIR) range, all of which have been utilized for 
imaging in biological systems in vitro and in vivo.  
 
8.1 In vitro photoluminescence imaging  
Individual semiconducting SWNTs have small bandgaps on the order of ~1eV, 
depending on the diameter and chirality of a given nanotube.  This bandgap allows for 
photoluminescence in the NIR range (900nm-1600nm) which is useful for biological 
imaging, due to the high optical transparency of biological tissue near 800nm-1000nm 
and inherently low autofluorescence from tissue in the NIR range [146].  SWNTs have a 
further advantage due to the large separation between the excitation (550nm-850nm) and 
emission bands (900nm-1600nm).  This spacing further reduces background from 
autofluorescence and Raman scattering.   
O’Connell et al. [23] first demonstrated NIR photoluminescence from micelle 
encapsulated SWNTs, yielding an estimated quantum efficiency of about 10-3.  Relying 
on this intrinsic NIR photoluminescence, Cherukuri et al. imaged nonspecific uptake of 
SWNTs in phagocytic cells [17].  In more recent work, Jin et al. user NIR 
photoluminescence to track endocytosis and exocytosis of SWNTs in NIH-3T3 cells in 
real time [95]. In our lab, we developed bio-inert PEGylated SWNTs conjugated with 
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antibodies as NIR fluorescent tags for selective probing of cell surface receptors [24].  
Figure 15 shows NIR fluorescence images of (b) BT-474, which is HER2/neu positive, 
and (c) MCF-7, which is HER2/neu negative, treated with a SWNT-Herceptin conjugate.  
We observed ultra-low NIR autofluorescence between different cell lines, demonstrating 
the advantage of SWNTs as a NIR fluorophore. 
There is still work to be done in the application of SWNTs as effective fluorophores. 
Bio-inert samples must be made with optimized quantum yields. Initial estimates of the 
quantum yield of SWNT suspensions were on the order of 10-3 or less [23, 147].  This 
seemed to contradict single tube studies with much higher quantum yield estimates of up 
to 0.07 [148].  Many factors contribute to the quantum yield including exciton quenching 
by bundles [149], sidewall defects [150], and length [151].  Crochet et al. showed that the 
quantum yield of bulk SWNT suspensions could be increased by an order of magnitude 
by centrifugation in an iodixanol gradient to remove bundled nanotubes [152].  Careful 
preparation techniques such as these need to be applied to making suspensions of pristine, 
unbundled SWNTs in bio-inert coatings, such as PL-PEG, in order to fully realize their 
potential as sensitive NIR fluorophores. 
 
8.2  In vitro Raman imaging 
Owing to their quasi 1-D nature, SWNTs exhibit strong resonance Raman scattering 
due to their sharp electronic density of states at the van Hove singularities. SWNTs have 
several unique Raman scattering features including the radial breathing mode (RBM) and 
tangential mode (G-band) [25], which are sharp and strong peaks that can be easily 
distinguished from fluorescence backgrounds, and thus are suitable for optical imaging. 
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We and Heller et al. have used Raman microscopy to image SWNTs in liver cells, as well 
as tissue slices, using either RBM peak or G-band peak of SWNTs [26, 45, 51, 58]. Our 
latest work showed that SWNTs with different isotope compositions exhibited shifted G 
band peaks, and thus could be used as multi-color contrast agents for multiplexed Raman 
imaging [127].  Cancer cells with different receptor expression profiles were selectively 
labeled with three isotopically unique formulations of “colored” SWNTs, conjugated 
with various targeting ligands including Herceptin (anti-Her2), Erbitux (anti-Her1) and 
RGD peptide, allowing for multi-color confocal Raman imaging of cells in a multiplexed 
manner using a single excitation (Fig. 16 c&d). SWNT Raman signals are highly robust 
against photo-bleaching, allowing long term imaging and tracking [26, 45]. With narrow 
peak features, SWNT Raman signals are easily differentiated from the auto-fluorescence 
background. The SWNT Raman excitation and scattering photons are in the near-infrared 
region, which is the most transparent optical window for biological systems in vitro and 
in vivo. Thus, SWNTs are novel Raman tags promising for multiplexed biological 
detection and imaging. 
 
8.3  SWNTs for in vivo animal imaging 
SWNT based biomedical imaging has also been conducted in animal models. The 
first-ever imaging of nanotubes inside a living animal was achieved by Weisman group in 
2007 [94]. In this work, drosophila larvae were fed by food containing SWNTs and 
imaged by NIR fluorescence microscope. The biodistribution of SWNTs in live larvae 
was monitored by the nanotube fluorescence signals. Recently, the Gambhir group 
successfully used RGD-conjugated PEGylated SWNTs provided by us as Raman probes 
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for in vivo tumor imaging in live mice (Fig. 17) [153, 154]. Intravenous injection of 
targeting SWNTs to living mice bearing a tumor xenograft, showed strong SWNT Raman 
signals in the tumor, while little signal was observed in the tumor upon injection of non-
targeted SWNTs. This is the first success of in vivo tumor imaging via carbon nanotube 
labels. 
SWNTs have strong optical absorption in the visible and NIR range. We and 
Chakravarty et al. have shown that SWNTs can be utilized as a photo-thermal therapeutic 
agents to kill cancer cells [20, 128]. NIR laser irradiation was used in both cases to 
generate heat, causing destruction of cancer cells with specific SWNT internalization. 
Beside its potential applications in therapy, the high optical absorption of SWNTs can 
also be utilized in photoacoustic imaging. Photoacoustic imaging, in which sounds are 
generated as a result of local heating by the absorption of laser light, has higher spatial 
resolution than traditional ultra-sound, and deeper tissue penetration than fluorescence 
imaging [155]. de la Zerda et al. used our RGD conjugated SWNTs as the contrast agent 
for photoacoustic molecular imaging of cancer in a mouse tumor model (Fig. 17) [22]. 
This work opens up new opportunities for in vivo biological imaging with SWNTs. 
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9. Summary and Prospective 
In this article, we have comprehensively reviewed the current research regarding the 
use of carbon nanotubes for biomedical applications. Various covalent and non-covalent 
chemistries have been developed to functionalize CNTs for biomedical research. Relying 
on their electric or optical properties, functionalized CNTs have been used for ultra-
sensitive detection of biological species. Surveying the literature, we clarify that in vitro 
and in vivo toxicities of CNTs are highly dependent on CNT functionalization. Well 
functionalized CNTs with biocompatible coatings are stable in biological solutions, and 
non-toxic in vitro to cells and in vivo to mice at the tested doses. Various reports have 
shown that CNTs are able to shuttle biological molecules including small drug molecules 
and biomacromolecules including proteins, plasmid DNA and siRNA into cells in vitro 
via an endocytosis pathway. In vivo behaviors including blood circulation, biodistribution 
and long term fate of CNTs have been studied in the past two years, showing dominant 
uptake of CNTs in RES organs, similar to most nanomaterials tested in vivo.  CNTs are 
able to target tumors by both passive targeting relying on the EPR effect and active 
targeting guided by targeting ligands, promising for in vivo cancer treatment. Moreover, 
SWNTs exhibit unique intrinsic optical properties and have been used for biological 
imaging in vitro and in vivo. 
Among all aspects, surface functionalization chemistry is the most essential and 
fundamental part for CNT biomedical applications. Highly hydrophilic coating, such as 
long and branched PEG on CNTs imparts ‘inertness’ in biological environments, 
minimizing the toxicity of CNTs and reducing non-specific binding (NSB) to biological 
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species, such as serum proteins and cell surface proteins. Minimal NSB is critical to 
enhance the detection sensitivity in CNT based biosenors and imaging probes. Decreased 
NSB reduces the non-specific endocytosis of CNTs, which is favored for targeted drug 
delivery to specific cell types. Similarly, the in vivo behaviors of CNTs are highly 
dependent on the nanotube surface coating. Prolonged blood circulation and reduced RES 
uptake can be achieved by using CNTs with highly hydrophilic coatings. Further efforts 
are required to optimize the surface chemistry of SWNTs, to further enhance 
biocompatibility. With improved surface coating, further improvements in biological 
sensing and imaging, better tumor targeting attributed to prolonged blood circulation and 
reduced RES uptake, and accelerated excretion, may be realized. By minimizing the non-
specific protein binding of nanotubes via improved surface functionalization, 
complement activation may also be reduced for SWNTs . 
CNTs, especially SWNTs are highly promising in biomedicine due to several 
features. CNTs are composed purely of carbon, while many inorganic nanomaterials (e.g. 
quantum dots) are composed of relatively more hazardous elements, such as heavy metals. 
The unique 1D structure and tunable length of CNTs provide an ideal platform to 
investigate size and shape effects in vivo. Lastly, unlike conventional organic drug 
carriers, the intrinsic physical properties of SWNTs including resonance Raman 
scattering, photoluminescence, and strong NIR optical absorption can provide valuable 
means of tracking, detecting and imaging. Taken together, CNTs may serve as a unique 
platform for potential multimodality cancer therapy and imaging. 
Although numerous encouraging results of using CNTs in biomedicine have been 
published in the past several years, much more work is still needed before CNTs can 
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enter the clinic. The most important issue to be addressed is still the concern of long-term 
toxicity. Although we have shown that well functionalized carbon nanotubes are not toxic 
in vitro to cells and in vivo to mice at our tested doses, further systematic investigations 
using different animal models at larger scales with various doses are required. Special 
attention should be paid to CNTs with surface functionalization optimized for such 
applications, with greater chances of minimizing toxic side-effects. 
Although we have succeeded in using carbon nanotubes for in vitro siRNA delivery, 
in vivo delivery of this type of biological macromolecules remains a challenge. There is a 
paradox existing due to the need of high in vitro cellular uptake and the requirement of 
favorable in vivo behaviors such as long blood circulation and low RES uptake of 
SWNTs. The former suggests reduced PEGylation of nanotubes, while the latter desires 
dense biocompatible surface coatings. Conjugation of targeting ligands on well coated 
SWNTs may help to solve this problem, allowing enhanced cellular uptake via receptor 
mediated endocytosis, without loss of optimal SWNT in vivo characteristics. Further 
development of suitable bioconjugation chemistry on nanotubes may create versatile 
SWNT based bioconjugates for actively targeted in vivo drug and gene delivery. 
Although not specifically discussed in this review, the fabrication of CNTs may also 
play important roles in their future biomedical applications. Most of CNT samples used 
in the published biomedical studies are heterogeneous mixtures of nanotubes with 
different lengths, diameters and chiralities. The lengths of CNTs may affect in vitro 
cellular uptake as well as in vivo pharmacokinetics of nanotubes. It is thus important to 
obtain and test nanotube samples with narrow length distributions. A density column 
based length separation method was established in our group [156]. Further studies will 
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uncover the potential length dependent effect of CNTs to their behaviors in biological 
systems. The electronic structures of SWNTs are determined by their chiralities (Fig. 1). 
Achieving SWNTs with single diameter and chirality may bring a revolution to the 
semiconductor industry and has been one of the ultimate goals of nanotube research for a 
decade.  Progresses have been made by selective synthesis of SWNTs at special 
conditions [157], removal of SWNTs with undesired diameters by etching [102], and 
chirality separation based on chromatography[73, 74]. Different semiconducting SWNTs 
with single chiralitiy compositions can serve as different colors in the NIR 
photoluminance imaging (Fig. 1). One the other hand, Raman scattering of SWNTs with 
single chirality will be largely enhanced because all nanotubes can be in the resonance 
with a selected excitation wavelength. The diameter dependent Raman RBM band of 
SWNTs may also be utilized in multi-color Raman imaging [25, 158]. CNT samples with 
homogenous length, diameter and chirality distributions are the ideal candidates for 
further studies in biomedicine. 
Lastly, biomedical imaging, based on the inherent physical properties of SWNTs, 
may be combined with drug delivery for multimodality cancer diagnosis and therapy. 
Phototherapy relying on the strong NIR light absorption ability of SWNTs may be 
conducted simultaneously, along with chemotherapy delivered by SWNTs, to enhance 
treatment efficacy in vivo. Despite challenges on the way towards the clinic, carbon 
nanotubes exhibit great potential for biomedicine, and may bring unprecedented 
opportunities for the future of cancer diagnosis and therapy. 
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